Clinical Trial Update: A Prospective, Randomized, Controlled Study of rhTPO in Combination With Herombopag + CsA vs Herombopag + CsA for the Treatment of Primary TD-NSAA [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial evaluating rhTPO with Herombopag and CsA versus Herombopag and CsA for primary TD-NSAA in aplastic anemia; current status unavailable…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• CSA (cyclosporine A)
• Herombopag (herombopag)
• rhTPO (recombinant human thrombopoietin)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Aplastic Anemia, Drug Effect | Phase 4 | Status: UNKNOWN